How To Use HCPCS Code C9148

HCPCS code C9148 describes the injection of teclistamab-cqyv, 0.5 mg. This code is used to identify the administration of this specific medication in a medical setting. In this article, we will explore the details of HCPCS code C9148, including its official description, procedure, when to use it, billing guidelines, historical information, Medicare and insurance coverage, and provide examples of when this code should be billed.

1. What is HCPCS C9148?

HCPCS code C9148 is a specific code used to identify the injection of teclistamab-cqyv, 0.5 mg. It is important for medical coders to accurately assign this code when reporting the administration of this medication. This code helps in tracking the usage and reimbursement of teclistamab-cqyv injections.

2. Official Description

The official description of HCPCS code C9148 is “Injection, teclistamab-cqyv, 0.5 mg.” This description clearly indicates that this code is specifically used for the injection of teclistamab-cqyv at a dosage of 0.5 mg.

3. Procedure

1. Prepare the teclistamab-cqyv injection according to the manufacturer’s instructions.
2. Verify the patient’s identity and confirm the correct dosage of 0.5 mg.
3. Select an appropriate injection site and clean the area with an antiseptic solution.
4. Administer the teclistamab-cqyv injection using the appropriate technique.
5. Observe the patient for any immediate adverse reactions or side effects.
6. Document the administration of teclistamab-cqyv in the patient’s medical record.

4. When to use HCPCS code C9148

HCPCS code C9148 should be used when a healthcare provider administers the teclistamab-cqyv injection to a patient. This code is specific to the injection of teclistamab-cqyv at a dosage of 0.5 mg and should not be used for any other medications or dosages.

5. Billing Guidelines and Documentation Requirements

When billing for the administration of teclistamab-cqyv using HCPCS code C9148, healthcare providers need to ensure proper documentation. This includes documenting the dosage administered, the date of administration, the patient’s identity, and any relevant information regarding the procedure. It is important to follow the billing guidelines set forth by the payer to ensure accurate reimbursement.

6. Historical Information and Code Maintenance

HCPCS code C9148 was added to the Healthcare Common Procedure Coding System on January 1, 1985. It has an effective date of January 1, 1996. As of June 30, 2023, this code has been terminated. The termination of a code means that it is no longer valid for use in medical coding and billing.

7. Medicare and Insurance Coverage

HCPCS code C9148 falls under the coverage code D, which indicates that special coverage instructions apply. Medicare and other insurance providers may have specific guidelines and requirements for the reimbursement of teclistamab-cqyv injections. The pricing indicator code for this code is 57, which means it is priced by other carriers. The multiple pricing indicator code is A, indicating that it is not applicable as HCPCS priced under one methodology.

8. Examples

Here are five examples of when HCPCS code C9148 should be billed:

1. A patient with multiple myeloma receives a teclistamab-cqyv injection at a dosage of 0.5 mg as part of their treatment regimen.
2. A healthcare provider administers a teclistamab-cqyv injection to a patient with relapsed or refractory multiple myeloma.
3. A clinical trial participant receives a teclistamab-cqyv injection as part of a research study.
4. A patient with a specific genetic mutation receives a teclistamab-cqyv injection as a targeted therapy.
5. A healthcare provider administers a teclistamab-cqyv injection to a patient as a palliative treatment option.